Correlation Between GM and Salarius Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both GM and Salarius Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GM and Salarius Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between General Motors and Salarius Pharmaceuticals, you can compare the effects of market volatilities on GM and Salarius Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GM with a short position of Salarius Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of GM and Salarius Pharmaceuticals.
Diversification Opportunities for GM and Salarius Pharmaceuticals
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between GM and Salarius is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding General Motors and Salarius Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Salarius Pharmaceuticals and GM is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on General Motors are associated (or correlated) with Salarius Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Salarius Pharmaceuticals has no effect on the direction of GM i.e., GM and Salarius Pharmaceuticals go up and down completely randomly.
Pair Corralation between GM and Salarius Pharmaceuticals
Allowing for the 90-day total investment horizon General Motors is expected to under-perform the Salarius Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, General Motors is 7.52 times less risky than Salarius Pharmaceuticals. The stock trades about -0.03 of its potential returns per unit of risk. The Salarius Pharmaceuticals is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 167.00 in Salarius Pharmaceuticals on December 27, 2024 and sell it today you would lose (81.00) from holding Salarius Pharmaceuticals or give up 48.5% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
General Motors vs. Salarius Pharmaceuticals
Performance |
Timeline |
General Motors |
Salarius Pharmaceuticals |
GM and Salarius Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with GM and Salarius Pharmaceuticals
The main advantage of trading using opposite GM and Salarius Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GM position performs unexpectedly, Salarius Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Salarius Pharmaceuticals will offset losses from the drop in Salarius Pharmaceuticals' long position.The idea behind General Motors and Salarius Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Salarius Pharmaceuticals vs. Akari Therapeutics PLC | Salarius Pharmaceuticals vs. Nutriband | Salarius Pharmaceuticals vs. SAB Biotherapeutics | Salarius Pharmaceuticals vs. GeoVax Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |